Related references
Note: Only part of the references are listed.webTWAS: a resource for disease candidate susceptibility genes identified by transcriptome-wide association study
Chen Cao et al.
NUCLEIC ACIDS RESEARCH (2022)
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
Moon Hee Lee et al.
ONCOIMMUNOLOGY (2022)
Comprehensive assessment of cellular senescence in the tumor microenvironment
Xiaoman Wang et al.
BRIEFINGS IN BIOINFORMATICS (2022)
A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes
Sizhe Wan et al.
HEPATOLOGY INTERNATIONAL (2022)
A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer
Dechao Feng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment
Ke Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer
Yufang Hou et al.
FRONTIERS IN IMMUNOLOGY (2022)
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
Ruidong Xue et al.
NATURE (2022)
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Brent R. Stockwell
CELL (2022)
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment
Han Luo et al.
NATURE COMMUNICATIONS (2022)
Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
Yuqin Tang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
Chengbin Guo et al.
FRONTIERS IN IMMUNOLOGY (2022)
Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma
Jingsong Shan et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Integrated transcriptomics unravels implications of glycosylation-regulating signature in diagnosis, prognosis and therapeutic benefits of hepatocellular carcinoma
Hua Tang et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Heterogeneity in NK Cell Subpopulations May Be Involved in Kidney Cancer Metastasis
Zhengfang Liang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
Zhiyong Cai et al.
FRONTIERS IN IMMUNOLOGY (2022)
Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
Hao Chi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy
John-William Sidhom et al.
SCIENCE ADVANCES (2022)
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
Stefan Salcher et al.
CANCER CELL (2022)
Pyroptosis predicts immunotherapy outcomes across multiple cancer types
Song Li et al.
CLINICAL IMMUNOLOGY (2022)
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara J. Laskowski et al.
NATURE REVIEWS CANCER (2022)
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma
Liqiang Tan et al.
THERANOSTICS (2022)
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
Yunfan Sun et al.
CELL (2021)
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Yuanyuan Zhang et al.
CANCER CELL (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds
Haiyan Wang et al.
SCIENCE ADVANCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Germline genetic contribution to the immune landscape of cancer
Rosalyn W. Sayaman et al.
IMMUNITY (2021)
Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer
Xingyu Chen et al.
ONCOGENE (2021)
Pan-cancer characterization of expression and clinical relevance of m6A-related tissue-elevated long non-coding RNAs
Kang Xu et al.
MOLECULAR CANCER (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma
Cheng-Peng Gui et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types
Sipeng Shen et al.
MOLECULAR CANCER (2021)
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma
Dan Bai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process
Chunling Shi et al.
Aging-US (2021)
Pyroptosis at the forefront of anticancer immunity
Reid Loveless et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
Tong Fu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Masatoshi Kudo et al.
JOURNAL OF HEPATOLOGY (2021)
An immunogenomic signature for molecular classification in hepatocellular carcinoma
Weiwei Zhuang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
Yousra Mohamed Abd-El-Halim et al.
EBIOMEDICINE (2021)
Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo
Huapan Fang et al.
NATURE COMMUNICATIONS (2021)
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy
Jing Sun et al.
ONCOIMMUNOLOGY (2021)
Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma
Fanhong Zeng et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
Run Shi et al.
THERANOSTICS (2021)
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
Jiao Hu et al.
THERANOSTICS (2021)
Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
Zheng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Zhiwei Zhou et al.
SCIENCE (2020)
Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer
Guanghui Gong et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immune-based therapies for hepatocellular carcinoma
David J. Pinato et al.
ONCOGENE (2020)
The Ubiquitin Gene Expression Pattern and Sensitivity toUBBandUBCKnockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells
Emanuele Salvatore Scarpa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit
Bailiang Li et al.
JCI INSIGHT (2020)
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
Peng-Fei Zhang et al.
MOLECULAR CANCER (2020)
Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma
Ankur Sharma et al.
CELL (2020)
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
Jae-Won Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
Baohui Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
Jianbo Pan et al.
NATURE COMMUNICATIONS (2020)
Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis
Yuqin Tang et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A novel nucleolin-binding peptide for Cancer Theranostics
Jae-Hyun Kim et al.
THERANOSTICS (2020)
Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients
Jing Sun et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer
Wang-Yu Cai et al.
THERANOSTICS (2020)
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
Jie-ying Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
TISIDB: an integrated repository portal for tumor-immune system interactions
Beibei Ru et al.
BIOINFORMATICS (2019)
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
Junyu Long et al.
EBIOMEDICINE (2019)
Chronic hypoxia-induced Cirbp hypermethylation attenuates hypothermic cardioprotection via down-regulation of ubiquinone biosynthesis
Yiwei Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
Jill M. Brooks et al.
CLINICAL CANCER RESEARCH (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Molecular characterization and clinical relevance of m6A regulators across 33 cancer types
Yongsheng Li et al.
MOLECULAR CANCER (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
Jennifer N. Brudno et al.
BLOOD REVIEWS (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients
Hansol Lee et al.
ONCOIMMUNOLOGY (2019)
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas
Lingpeng Yang et al.
PEERJ (2019)
Projections of primary liver cancer to 2030 in 30 countries worldwide
Patricia C. Valery et al.
HEPATOLOGY (2018)
High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies
Baixin Ye et al.
CANCER LETTERS (2018)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Hallmarks of Cellular Senescence
Alejandra Hernandez-Segura et al.
TRENDS IN CELL BIOLOGY (2018)
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu et al.
CANCER RESEARCH (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C. Hopkins et al.
JCI INSIGHT (2018)
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
David Balli et al.
CLINICAL CANCER RESEARCH (2017)
Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy
Lisa Rosenbaum
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma
Yingxin Han et al.
CANCER LETTERS (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Cold-inducible RNA-binding protein promotes the development of liver cancer
Toshiharu Sakurai et al.
CANCER SCIENCE (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Catherine de Martel et al.
HEPATOLOGY (2015)
Metabolic Reprogramming of Immune Cells in Cancer Progression
Subhra K. Biswas
IMMUNITY (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
Lidia Robert et al.
CLINICAL CANCER RESEARCH (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Identification of SERPINB1 As a Physiological Inhibitor of Human Granzyme H
Li Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
A Role for Plk1 phosphorylation of NudC in cytokinesis
T Zhou et al.
DEVELOPMENTAL CELL (2003)
Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis
JP Aumais et al.
JOURNAL OF CELL SCIENCE (2003)